Early rheumatoid arthritis: a medical emergency?

The American Journal of Medicine

Volume 111, Issue 6, 15 October 2001, Pages 498-500

The assistance of Bettie Stone in preparing the manuscript and the helpful comments from Gene Ball, MD, and Ted Mikuls, MD, are much appreciated.

L.R. Lard et al.
Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies
Am J Med
(2001)
M. Boers et al.
Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
Lancet
(1997)
J.N. Katz et al.
Utilization of rheumatology physician services by the elderly
Am J Med
(1998)
C. Egsmose et al.
Patients with rheumatoid arthritis benefit from early 2nd line therapy5-year follow-up of a prospective double blind placebo controlled study
J Rheumatol
(1995)
A. van der Heide et al.
The effectiveness of early treatment with “second-line” antirheumatic drugs
Ann Intern Med
(1996)
P.A. Reilly et al.
Mortality and survival in rheumatoid arthritisa 25 year prospective study of 100 patients
Ann Rheum Dis
(1990)
H.G. Birnbaum et al.
Direct and indirect costs of rheumatoid arthritis to an employer
J Occup Environ Med
(2000)
J.M. Bathon et al.
A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis
N Engl J Med
(2000)
E. Tsakonas et al.
Consequences of delayed therapy with second-line agents in rheumatoid arthritisa 3-year follow-up on the Hydroxychloroquine in Early Rheumatoid Arthritis (HErheumatoid arthritis) Study
J Rheumatol
(2000)
A.A.M.E. Stenger et al.
Early effective suppression of inflammation in rheumatoid arthritis reduces radiographic progression
Br J Rheumatol
(1998)

There are more references available in the full text version of this article.